- Report
- April 2024
- 172 Pages
Global
From €2188EUR$2,500USD£1,902GBP
- Report
- May 2024
- 175 Pages
Global
From €2188EUR$2,500USD£1,902GBP
- Report
- January 2024
- 143 Pages
Global
From €2790EUR$3,188USD£2,425GBP
€3719EUR$4,250USD£3,233GBP
- Report
- December 2024
- 34 Pages
Global
From €3496EUR$3,995USD£3,039GBP
- Report
- September 2023
- 1105 Pages
Global
From €2188EUR$2,500USD£1,902GBP
- Report
- November 2022
- 107 Pages
Global
From €3457EUR$3,950USD£3,005GBP
- Report
- December 2023
- 180 Pages
Global
From €1094EUR$1,250USD£951GBP
€2188EUR$2,500USD£1,902GBP
- Report
- December 2023
- 80 Pages
United States
From €1313EUR$1,500USD£1,141GBP
- Report
- December 2023
- 80 Pages
United Kingdom
From €1313EUR$1,500USD£1,141GBP
From €1313EUR$1,500USD£1,141GBP
- Report
- December 2023
- 80 Pages
South Korea
From €1313EUR$1,500USD£1,141GBP
- Report
- December 2023
- 80 Pages
Saudi Arabia
From €1313EUR$1,500USD£1,141GBP
- Report
- December 2023
- 80 Pages
Russia
From €1313EUR$1,500USD£1,141GBP
- Report
- December 2023
- 80 Pages
Poland
From €1313EUR$1,500USD£1,141GBP
- Report
- December 2023
- 80 Pages
India
From €1313EUR$1,500USD£1,141GBP
- Report
- December 2023
- 80 Pages
Germany
From €1313EUR$1,500USD£1,141GBP
- Report
- December 2023
- 80 Pages
France
From €1313EUR$1,500USD£1,141GBP
- Report
- December 2023
- 80 Pages
China
From €1313EUR$1,500USD£1,141GBP
- Report
- June 2023
- 27 Pages
Global
€10721EUR$12,250USD£9,320GBP
- Report
- October 2023
- 87 Pages
Global
From €3500EUR$4,284USD£3,149GBP

The Eczema Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Eczema drugs are used to treat the symptoms of eczema, a chronic skin condition characterized by red, itchy, and inflamed skin. These drugs are typically topical creams, ointments, and lotions, and may contain corticosteroids, calcineurin inhibitors, and other active ingredients. In addition to treating the symptoms of eczema, these drugs may also help to reduce the risk of infection and improve the overall quality of life for those affected by the condition.
Some companies in the Eczema Drug market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Mylan. Show Less Read more